Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network
- PMID: 28334336
- PMCID: PMC5567866
- DOI: 10.1001/jamaophthalmol.2017.0089
Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network
Abstract
Importance: Ophthalmic screening to check for diabetic retinopathy (DR) is important to prevent vision loss in persons with diabetes. The American Academy of Ophthalmology recommends that ophthalmic screening for DR occur beginning at 5 years after initial diabetes diagnosis for youths with type 1 diabetes; the American Diabetes Association recommends screening of youths with type 2 diabetes at the time of initial diagnosis. To our knowledge, it is unknown to what extent youths with diabetes obtain eye examinations in accordance with these guidelines.
Objective: To assess the rate of obtaining ophthalmic examinations and factors associated with receipt of eye examinations for youths with diabetes.
Design, setting, and participants: This retrospective, longitudinal cohort study examined youths 21 years or younger with newly diagnosed diabetes enrolled in a US managed care network from January 1, 2001, through December 31, 2014.
Main outcomes and measures: Kaplan-Meier survival curves estimated the time from initial diabetes diagnosis to first eye examination by an ophthalmologist or optometrist. Multivariable Cox proportional hazards regression models identified factors associated with receiving an ophthalmic examination after initial diabetes diagnosis.
Results: Among 5453 youths with type 1 diabetes (median age at initial diagnosis, 11 years; interquartile range, 8-15 years; 2972 male [54.5%]; 4505 white [82.6%]) and 7233 youths with type 2 diabetes (median age at initial diagnosis, 19 years; interquartile range, 16-22 years; 1196 male [16.5%]; 5052 white [69.9%]), 64.9% of patients with type 1 diabetes and 42.2% of patients with type 2 diabetes had undergone an eye examination by 6 years after initial diabetes diagnosis. Black youths (1367 [10.8%] of the sample) had an 11% and Latino youths (1450 [11.4%] of the sample) had an 18% decreased hazard of undergoing an eye examination by 6 years compared with white youths (black youths: adjusted hazard ratio [HR], 0.89; 95% CI, 0.79-0.99; Latino youths: HR, 0.82; 95% CI, 0.73-0.92). As household net worth increased, youths were increasingly more likely to undergo an eye examination by 6 years after initial diabetes diagnosis (net worth of ≥$500 000 vs <$25 000: HR, 1.50; 95% CI, 1.34-1.68).
Conclusions and relevance: Despite possessing health insurance, many youths with diabetes are not receiving eye examinations by 6 years after initial diagnosis to monitor for DR. These data suggest that adherence to clinical practice guidelines is particularly challenging for racial minorities and youths from less affluent families.
Conflict of interest statement
Figures
Comment in
-
Diabetic Retinopathy Screening With Telemedicine: A Potential Strategy to Engage Our Youth.JAMA Ophthalmol. 2017 May 1;135(5):438-439. doi: 10.1001/jamaophthalmol.2017.0150. JAMA Ophthalmol. 2017. PMID: 28334299 No abstract available.
Similar articles
-
Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.Ophthalmology. 2017 Apr;124(4):424-430. doi: 10.1016/j.ophtha.2016.10.031. Epub 2016 Nov 30. Ophthalmology. 2017. PMID: 27914837 Free PMC article.
-
Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths.JAMA Ophthalmol. 2021 Jul 1;139(7):791-795. doi: 10.1001/jamaophthalmol.2021.1551. JAMA Ophthalmol. 2021. PMID: 34042939 Free PMC article.
-
Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use.JAMA Ophthalmol. 2016 Nov 1;134(11):1221-1228. doi: 10.1001/jamaophthalmol.2016.3081. JAMA Ophthalmol. 2016. PMID: 27632231
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
-
Diabetes-related eye disorders.J Natl Med Assoc. 1993 Feb;85(2):104-8. J Natl Med Assoc. 1993. PMID: 8441184 Free PMC article. Review.
Cited by
-
Clinical Implementation of Autonomous Artificial Intelligence Systems for Diabetic Eye Exams: Considerations for Success.Clin Diabetes. 2024 Winter;42(1):142-149. doi: 10.2337/cd23-0019. Epub 2023 Sep 18. Clin Diabetes. 2024. PMID: 38230333 Free PMC article. No abstract available.
-
Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial.Nat Commun. 2024 Jan 11;15(1):421. doi: 10.1038/s41467-023-44676-z. Nat Commun. 2024. PMID: 38212308 Free PMC article. Clinical Trial.
-
Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models.Sci Rep. 2023 Apr 13;13(1):6047. doi: 10.1038/s41598-023-33365-y. Sci Rep. 2023. PMID: 37055475 Free PMC article.
-
Prevalence, Progression, and Modifiable Risk Factors for Diabetic Retinopathy in Youth and Young Adults With Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth Study.Diabetes Care. 2023 Jun 1;46(6):1252-1260. doi: 10.2337/dc22-2503. Diabetes Care. 2023. PMID: 37043887 Free PMC article.
-
Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.JAMA Netw Open. 2023 Mar 1;6(3):e231887. doi: 10.1001/jamanetworkopen.2023.1887. JAMA Netw Open. 2023. PMID: 36930156 Free PMC article.
References
-
- Green A, Patterson CC EURODIAB TIGER Study Group. Trends in the incidence of childhood-onset diabetes in Europe 1989–1998. Diabetologia. 2001;44(3 suppl 3):B3–B8. - PubMed
-
- Day C. The rising tide of type 2 diabetes. Br J Diabetes Vasc Dis. 2001;1(1):37–43.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
